Clinical trial
Effect of Rosiglitazone on ADMA in Critical Illness
NCT00409097 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Rosiglitazone on ADMA in Critical Illness
- Lead sponsor
- Amsterdam UMC, location VUmc
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 30, 2006
- Completion date
- December 31, 2007
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.